| Jul 15 |
Novartis Q2 Earnings Preview: Positive Fundamental Trends Should Continue
|
| Jul 15 |
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
|
| Jul 15 |
Goldman and Bank of America Earnings, ECB Rate Decision: What to Watch This Week
|
| Jul 12 |
Leqembi sales inch higher; Spark’s pivot leads to layoffs
|
| Jul 12 |
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
|
| Jul 8 |
UK pharma group reprimands Novo Nordisk for undisclosed payments
|
| Jul 8 |
Novartis Stock Generating Improved Relative Strength
|
| Jul 5 |
Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
|
| Jul 5 |
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
|
| Jun 26 |
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
|
